Sign in
ARYX Stock Price, Chart, Stats & News
ARYx Therapeutics, Inc.
Save
ARYx Therapeutics, Inc. (ARYX) does not currently pay a dividend.
16,731
Market cap
–
Current P/E
–
Forward P/E
ARYX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients.
Similar securities
Based on sector and market capitalization
Report issue